The ideal joint replacement for CMC thumb arthritis.
Clinicians and patients agree: The need is clear.
CMC thumb osteoarthritis is estimated to occur in up to 15% of adults, including 14% of adults 50-59 and 24% of adults 60-92. That’s a lot of people in a lot of pain.
The ZEPART® Implant
Returning patients to their best.
As demand for effective thumb CMC arthritis treatment grows, both patients and surgeons seek CMC arthritis surgery options that can provide lasting pain relief and restore hand function. Current CMC OA treatment options have tradeoffs, often compromising functional movement or grip strength for pain relief. While outcomes from these treatments are passable, they leave much to be desired, especially for patients with active lifestyles.
A solution without compromise.
At Sandia Medical Technologies we believe in developing solutions without compromises. The ZEPART implant isn’t designed so patients can get by. It’s designed to return patients to their best.
Developed by Sandia Medical Technologies in Albuquerque, New Mexico.
Our all-star team is the emerging R&D leader for orthopedic surgery and related fields.
